Browsing by Author Dotor, J. (Javier)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 17 of 17
Issue DateTitleTypeAuthor(s)
2003A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injuryArticuloEzquerro, I.J. (Ignacio José); Lasarte, J.J. (Juan José); Dotor, J. (Javier); Castilla-Cortazar, I. (Inma); Bustos, M. (Matilde); Peñuelas-Sanchez, I. (Ivan); Blanco, G. (Gemma); Rodriguez-Ortigosa, C.M. (Carlos M.); Lechuga, M.C.G. (María del Carmen G.); Greenwel, P. (Patricia); Rojkind, M. (Marcos); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco)
2009A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive ratsArticuloHermida, N. (Nerea); Lopez-Salazar, M.B. (María Begoña); Gonzalez, A. (Arantxa); Dotor, J. (Javier); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Borras-Cuesta, F. (Francisco); Diez-Martinez, J. (Javier)
2012Blockade of TGF-β 1 Signalling Inhibits Cardiac NADPH Oxidase Overactivity in Hypertensive RatsArticuloMiguel-Carrasco, J.L. (José Luis); Baltanas, A. (Ana); Cebrian, C. (Carolina); Moreno, M.U. (María Ujué); Lopez-Salazar, M.B. (María Begoña); Hermida, N. (Nerea); Gonzalez, A. (Arantxa); Dotor, J. (Javier); Borras-Cuesta, F. (Francisco); Diez-Martinez, J. (Javier); Fortuño, A. (Ana); Zalba, G. (Guillermo)
2003CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccinationArticuloCasares, N. (Noelia); Arribillaga, L. (Laura); Sarobe, P. (Pablo); Dotor, J. (Javier); Lopez-Diaz-de-Cerio, A. (Ascensión); Melero, I. (Ignacio); Lasarte, J.J. (Juan José)
8-Jun-2016Characterization of cellular and molecular responses of human glioblastoma to Transforming Growth Factor-β signalling pathway inhibitionTesisGallo, G.O. (Gabriel Osvaldo)
2008Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effectsArticuloLlopiz, D. (Diana); Dotor, J. (Javier); Zabaleta, A. (Aintzane); Lasarte, J.J. (Juan José); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco); Sarobe, P. (Pablo)
2002Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacementsArticuloHuarte, E. (Eduardo); Sarobe, P. (Pablo); Lu, J. (Jun); Casares, N. (Noelia); Lasarte, J.J. (Juan José); Dotor, J. (Javier); Ruiz, M. (Marta); Prieto, J. (Jesús); Celis, E. (Esteban); Borras-Cuesta, F. (Francisco)
May-2014Harnessing high density lipoproteins to block transforming growth factor beta and to inhibit the growth of liver tumor metastasesArticuloMedina-Echeverz, J. (José); Fioravanti, J. (Jessica); Diaz-Valdes, N. (Nancy); Frank, K. (Kathrin); Aranda, F. (Fernando); Gomar, C. (Celia); Ardaiz, N. (Nuria); Dotor, J. (Javier); Umansky, V. (Viktor); Prieto, J. (Jesús); Berraondo, P. (Pedro)
2007Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide libraryArticuloDotor, J. (Javier); Lopez-Vazquez, A.B. (Ana B.); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Garcia-Granero, M. (Marta); Riezu-Boj, J.I. (José Ignacio); Martinez, A. (Alfonso); Feijoo, E. (Esperanza); Lopez-Sagaseta, J. (Jacinto); Hermida, J. (José); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco)
2008In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1ArticuloGil-Guerrero, L. (Lucía); Dotor, J. (Javier); Huibregtse, I.L. (Inge Louise); Casares, N. (Noelia); Lopez-Vazquez, A.B. (Ana B.); Rudilla, F. (Francesc); Riezu-Boj, J.I. (José Ignacio); Lopez-Sagaseta, J. (Jacinto); Hermida, J. (José); Deventer, S. (Sander) van; Bezunartea, J. (Jaione); Llopiz, D. (Diana); Sarobe, P. (Pablo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco); Lasarte, J.J. (Juan José)
2011Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppressionArticuloDiaz-Valdes, N. (Nancy); Basagoiti, M. (María); Dotor, J. (Javier); Aranda, F. (Fernando); Monreal, I. (Iñaki); Riezu-Boj, J.I. (José Ignacio); Borras-Cuesta, F. (Francisco); Sarobe, P. (Pablo); Feijoo, E. (Esperanza)
2007Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40ArticuloZabaleta, A. (Aintzane); Arribillaga, L. (Laura); Llopiz, D. (Diana); Dotor, J. (Javier); Lasarte, J.J. (Juan José); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco); Esteban, J.I. (Juan Ignacio); Quer, J. (Josep); Vayreda, F. (Francesc); Sarobe, P. (Pablo)
2009Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapyArticuloLlopiz, D. (Diana); Dotor, J. (Javier); Casares, N. (Noelia); Bezunartea, J. (Jaione); Diaz-Valdes, N. (Nancy); Ruiz, M. (Marta); Aranda, F. (Fernando); Berraondo, P. (Pedro); Prieto, J. (Jesús); Lasarte, J.J. (Juan José); Borras-Cuesta, F. (Francisco); Sarobe, P. (Pablo)
2008TGFbeta-induced protein mediates lymphatic endothelial cell adhesion to the extracellular matrix under low oxygen conditionsArticuloIrigoyen, M. (Marta); Anso, E. (Elena); Salvo, E. (Elizabeth); Dotor, J. (Javier); Martinez-Irujo, J.J. (Juan José); Rouzaut, A. (Ana)
2011Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosisArticuloArribillaga, L. (Laura); Dotor, J. (Javier); Basagoiti, M. (María); Riezu-Boj, J.I. (José Ignacio); Borras-Cuesta, F. (Francisco); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Cornet, M.E. (María Eugenia); Feijoo, E. (Esperanza)
2005Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosisArticuloSantiago, B. (Begoña); Gutierrez-Cañas, I. (Irene); Dotor, J. (Javier); Palao, G. (Guillermo); Lasarte, J.J. (Juan José); Ruiz, J. (Juan); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco); Pablos, J.L. (José L.)
31-May-2013Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptidesArticuloZarranz-Ventura, J. (Javier); Fernandez-Robredo, P. (Patricia); Recalde, S. (Sergio); Salinas-Alaman, A. (Ángel); Borras-Cuesta, F. (Francisco); Dotor, J. (Javier); Garcia-Layana, A. (Alfredo)